Schott Nexterion, Operon Biotechnologies to Co-Market New Microarray Kit | GenomeWeb

NEW YORK, April 13 (GenomeWeb News) - Schott Nexterion and Operon Biotechnologies will co-market a kit-based product for microarrays with components that cover every step in the microarray process chain.

 

The kit is composed of oligonucleotide sets, microarray slides, and reagents, the duo said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.